Aim immunotech files definitive proxy statement and sends letter to shareholders

Ocala, fla.--(business wire)--aim immunotech inc. (nyse american: aim) (“aim” or the “company”) today announced that the company has filed its definitive proxy statement in connection with aim's upcoming 2023 annual meeting of stockholders (the “2023 annual meeting”), scheduled for december 1, 2023. the company also sent a letter to shareholders in connection with the annual meeting. additionally, aim has launched www.safeguardaim.com to keep shareholders up to date on key developments. the ful.
AIM Ratings Summary
AIM Quant Ranking